Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Capital/Financing Update 2011

Dec 5, 2011

64741_rns_2011-12-05_08fa7828-b099-4cb5-b915-0ff4d213f5aa.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [167 x 59] intentionally omitted <==

cyclo medica molecular imaging techne gas Cyclopharm Ltd ABN 74 116 931 250 Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW 2234 Australia POB 350 Menai Central NSW 2234 T 61 2 9541 0411 F 61 2 9543 0960 www.cyclopharm.com.au

Tuesday 6 December 2011

Completion of Rights Issue and notice of under subscriptions

Cyclopharm Limited ( Company ) today announced the completion of the renounceable prorata entitlement offer ( Rights Issue ) announced on 4 November 2011.

At the closing date, the Company received subscriptions for 31,724,692 shares. The shortfall of 20,842,110 shares will be fully taken up by the Underwriter in accordance with the underwriting agreement.

==> picture [109 x 29] intentionally omitted <==

James McBrayer Managing Director

corporate/850146_1